Cindy Gibson is an Associate Director of Clinical Contracts Review at Sarepta Therapeutics, with over 30 years of experience in pharmaceutical contracting, clinical operations support, and regulatory-compliant agreement negotiation. She has lead the end-to-end review and negotiation of global clinical trial agreements, country-level CTAs, site budgets, and amendments, partnering closely with CROs, legal, finance, procurement, and clinical operations teams to protect business interests while enabling timely study execution. Cindy was promoted to Associate Director in March 2026.

Throughout her career, Cindy has supported all phases of the clinical trial lifecycle across Phases I–IV, including, site budget development, CRO negotiations, and contract risk mitigation. Prior to Sarepta, she held roles at Novartis Gene Therapies, AbbVie, Abbott Laboratories, Hospira, and TAP Pharmaceuticals, where she negotiated a wide range of agreements including CTAs, investigator-initiated trials, consulting agreements, service agreements, Master Service Agreements and federal government supply contracts.

Cindy holds a Bachelor of Arts in Management and Communication from Concordia University, a Paralegal Certificate from Carthage College, and completed Commercial Contract Fundamentals through UC Berkeley School of Law in 2025.